Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001237334-26-000004

Director sold 20 shares at $490.17 ($9,803)

  • Director acquired 20 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

CAUSEY CHRISTOPHER · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-04 Exercise or conversion : show line 1 in the form 10b5-1 +20 $119.76 $2,395 4,210 D
2026-03-04 Sale : show line 2 in the form 10b5-1 −20 $490.17 $9,803 4,190 D
Open-market sales · 20 sh · avg $490.17 · $9,803

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-04 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option −20 6,300 D
Loading xslF345X05/primarydocument.xml…